Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

Mar 30, 2016 7:00am EDT

Heat Biologics to Participate in the 6th Annual Cancer Immunotherapy: A Long-Awaited Reality Conference

Mar 23, 2016 11:05am EDT

Heat Biologics Announces Closing of Public Offering

Mar 18, 2016 8:30am EDT

Heat Biologics Announces Public Offering of Common Stock and Warrants

Mar 09, 2016 7:00am EST

Heat Biologics’ CSO to Participate in the 27th Annual Cancer Progress Conference by Defined Health

Mar 07, 2016 4:05pm EST

Heat Biologics Presents Positive ComPACT Preclinical Data at the Keystone Symposia

Mar 04, 2016 7:00am EST

Heat Biologics to Present at the 28th Annual ROTH Conference

Feb 25, 2016 7:00am EST

Heat Biologics Provides Update on Its HS-410 Phase 2 Monotherapy Bladder Cancer Trial Arm

Feb 18, 2016 7:00am EST

Heat Biologics Reports Fiscal Year 2015 Financial Results

Feb 10, 2016 7:00am EST

FDA Lifts Heat Biologics Partial Clinical Hold

Feb 03, 2016 7:00am EST

Heat Biologics Reports Update on Its HS-410 Phase 2 Bladder Cancer Trial

rss_feed News RSS